Background and Study Aims: In recent years, short-segment Barrett’s esophagus (SSBE) has attracted increasing attention in the context of reflux disease. However, there is continuing controversy regarding its potential for malignant transformation.
Patients and Methods: Between October 1996 and September 1999, 50/115 patients (43 %) with intraepithelial high-grade neoplasia or early Barrett’s adenocarcinoma, who underwent local endoscopic treatment, had developed a malignant lesion in an (SSBE). In the framework of a prospective observational study, 28 patients were treated with endoscopic mucosal resection (EMR), 13 with photodynamic therapy, and three with argon plasma coagulation; six patients received combinations of these treatments.
Results: Complete local remission was achieved in 48/49 patients (98 %). One patient switched to surgery after the first EMR, because there was submucosal tumor infiltration, and in one patient out of 50 local endoscopic treatment failed. A mean of 1.7 ± 1.4 treatment sessions was required for local endoscopic treatment. The method-associated mortality was 0 %. The rate of relevant complications (stenosis, bleeding) was 6 % (3/50 patients). No cases of severe hemorrhage (Hb fall >2 g/dl) or perforation occurred. During a mean follow-up period of 34 ± 10 months, metachronous intraepithelial high-grade neoplasms or early adenocarcinomas were seen in 11/48 patients (23 %), who received further successful endoscopic treatment. Four patients died during the follow-up period, but in only one patient was this due to his Barrett’s adenocarcinoma (this was the patient who underwent esophageal resection).
Conclusions: The malignant potential of short-segment Barrett’s esophagus must not be underestimated. Organ-preserving local endoscopic treatment shows good acute-phase and long-term results. Local endoscopic treatment represents an alternative to esophageal resection in the case of intraepithelial high-grade neoplasia and selected early adenocarcinomas in Barrett’s esophagus.
References
1
Spechler S J, Zeroogian J M, Antonioli D A.
Prevalence of metaplasia at the gastro-oesophageal junction.
Lancet.
1994;
344
1533-1536
2
Weston A P, Krmpotich P, Cherian R. et al .
Short segment Barrett’s esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia.
Am J Gastroenterol.
1996;
91
981-986
3
Johnston M H, Hammond A S, Laskin W, Jones D M.
The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy.
Am J Gastroenterol.
1996;
91
1507-1511
4
Sharma P, Morales T G, Sampliner R E.
Short segment Barrett’s esophagus: the need for standardization of the definition and of endoscopic criteria.
Am J Gastroenterol.
1998;
93
1033-1036
5
Nandukar S, Talley N J.
Barrett’s esophagus: the long and the short of it.
Am J Gastroenterol.
1999;
94
30-40
6
Hirota W K, Loughney T M, Lazas D J. et al .
Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.
Gastroenterology.
1999;
116
277-285
7
Donahue D, Navab F.
Significance of short-segment Barrett’s esophagus.
J Clin Gastroenterol.
1997;
25
480-484
8
Sharma P, Morales T G, Bhattacharyya A. et al .
Dysplasia in short-segment Barrett’s esophagus: a prospective 3-year follow-up.
Am J Gastroenterol.
1997;
92
2012-2016
9
Weston A P, Krmpotich P T, Cherian R. et al .
Prospective long-term endoscopic and histological follow-up of short segment Barrett’s esophagus: comparison with traditional long segment Barrett’s esophagus.
Am J Gastroenterol.
1997;
92
407-413
10
Rudolph R E, Vaughan T L, Storer B E. et al .
Effect of segment length on risk for neoplastic progression in patients with Barrett’s esophagus.
Ann Intern Med.
2000;
132
612-620
11
Gossner L, May A, Pech O. et al .
Chromoendoscopy for the detection of dysplasia or mucosal cancer in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2000;
51
AB120 (3537)
12 Watanabe H, Jass J R, Sobin L H. Histological typing of oesophageal and gastric tumors. 2nd edn. Berlin; Springer 1990
13
Schlemper R J, Riddell R H, Kato Y. et al .
The Vienna classification of gastrointestinal epithelial neoplasia.
Gut.
2000;
47
251-255
14 Nishi M, Omori Y, Miwa K. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. 1st English edn. Tokyo; Kanehara 1995
15
Ell C, May A, Gossner L. et al .
Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett’s esophagus.
Gastroenterology.
2000;
118
670-677
16
Ell C, May A, Wurster H.
The first reusable multiple band ligator for endoscopic hemostasis of variceal bleeding, nonvariceal bleeding and mucosal resection.
Endoscopy.
1999;
31
1-3
17
Barr H, Shepherd N A, Dix A. et al .
Eradication of high grade dysplasia in columnar-lined (Barrett’s) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.
Lancet.
1996;
348
584-585
18
Gossner L, Stolte M, Sroka R. et al .
Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid.
Gastroenterology.
1998;
114
448-455
19
Gossner L, May A, Sroka R. et al .
Photodynamic destruction of high grade dysplasia and early carcinoma of the esophagus after oral administration of 5-aminolevulinic acid.
Cancer.
1999;
86
1921-1928
20
Byrne J P.
Restoration of the normal squamous lining in Barrett’s esophagus by argon beam plasma coagulation.
Am J Gastroenterol.
1998;
93
1810-1815
21
van den Boogert J, van Hillegersberg R, Siersema P D. et al .
Endoscopic ablation therapy for Barrett’s esophagus with high grade dysplasia: a review.
Am J Gastroenterol.
1999;
94
1153-1160
22
Gossner L, May A, Stolte M. et al .
KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett’s esophagus.
Gastrointest Endosc.
1999;
49
8-12
23
Kaplan E L, Meier P.
Nonparametric estimation from incomplete observations.
J Am Stat Assoc.
1958;
53
457-481
24
Cameron A J, Carpenter H A.
Barrett’s esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
Am J Gastroenterol.
1997;
92
586-591
25
Inoue H, Takeshita K, Hori H. et al .
Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach and colon mucosal lesions.
Gastrointest Endosc.
1993;
39
58-62
26
Ackroyd R, Brown N J, Davis M F, Stephenson T J. et al .
Photodynamic therapy for dysplastic Barrett’s esophagus: a prospective, double blind, randomised, placebo controlled trial.
Gut.
2000;
47
612-617
27
Heitmiller R F, Redmond M, Hamilton S R.
Barrett’s esophagus with high grade dysplasia: an indication for prophylactic esophagectomy.
Ann Surg.
1996;
224
66-71
28
Hölscher A H, Bollschweiler E, Schneider P M, Siewert J R.
Early adenocarcinoma in Barrett’s oesophagus.
Br J Surg.
1997;
84
1470-1473
29
Nigro J J, Hagen J A, DeMeester T R. et al .
Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy.
Ann Surg.
1999;
230
433-440
30
Stein H J, Feith M, Mueller J. et al .
Limited resection for early adenocarcinoma in Barrett’s esophagus.
Ann Surg.
2000;
232
733-742
C. Ell, M.D., Ph.D.
Department of Internal Medicine II · HSK Wiesbaden
Ludwig-Erhard-Straße 100 · 65199 Wiesbaden · Germany
Fax: + 49-611-432418
eMail: Med2.hsk-wiesbaden@knuut.de